EVMN

Evommune INC

+$327.7M

Net Activity

Institutions Holding

84

Popularity Rank

#4838

Avg Weight

2.03%

Total Value

$793.4M

Ownership Trend

84 institutions currently hold EVMN, with 60 net buyers and 20 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Significantly Increased

Based on recent trading activity

Net Selling Institutions

20

Net Buying Institutions

60

Key Holders

View all 84 holding institutions

Quarterly Activity

Recent Activity

+$422.2M

Total Buy Value

$72.6M

Total Sell Value

New buy34
Trim11
Add26
Sold out9

60

Net Buyers

20

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

1

Filings (90d)

$427K

Total Est. Value

20K shares

Planned Shares

Last Filed 2026-06-22
FilerFiling DateEst. Value
Drew Janice Suzann2026-06-22$427K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding EVOMMUNE INC (EVMN)?
Major stakeholders currently include EQT Fund Management S.a r.l. ($113.3M), Ra Capital Management, L.p. ($80.3M), Pivotal bioVenture Partners Investment Advisor LLC ($44.3M). Based on the latest 13F filings, there are a total of 84 tracked investment funds and institutions maintaining positions in EVMN.
What is the overall institutional sentiment toward EVMN recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $327.7M, driven by 60 managers accumulating shares while 20 reduced their exposure.
Which institutions have been selling or reducing their EVMN positions?
In the latest period, 11 funds trimmed their holdings, and 9 managers completely exited their positions. The aggregate reported sell value was $72.6M.
Are there any notable investors adding EVMN to their portfolios?
Yes, buying activity remains notable. 34 institutions opened new positions in {ticker}, and 26 existing holders added to their shares. The total reported buy value for the quarter amounted to $422.2M.

Related Stocks